|
NL6815872A
(https=)
|
1967-11-22 |
1969-05-27 |
|
|
|
JPS5614663B2
(https=)
|
1971-08-21 |
1981-04-06 |
|
|
|
US4582833A
(en)
|
1984-04-16 |
1986-04-15 |
American Cyanamid Company |
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
|
|
US4576943A
(en)
|
1984-10-09 |
1986-03-18 |
American Cyanamid Company |
Pyrazolo[1,5-a]pyrimidines
|
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
AU1952597A
(en)
|
1996-02-13 |
1997-09-02 |
G.D. Searle & Co. |
Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
|
|
US5952349A
(en)
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
JP2000516611A
(ja)
|
1996-08-14 |
2000-12-12 |
ワーナー―ランバート・コンパニー |
Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
|
|
US6309561B1
(en)
|
1997-12-24 |
2001-10-30 |
3M Innovative Properties Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
|
US6380203B1
(en)
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
GB9815880D0
(en)
|
1998-07-21 |
1998-09-16 |
Pfizer Ltd |
Heterocycles
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US6924313B1
(en)
|
1999-09-23 |
2005-08-02 |
Pfizer Inc. |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
|
|
WO2001056990A2
(en)
|
2000-02-03 |
2001-08-09 |
Eli Lilly And Company |
Pyridine derivates as potentiators of glutamate receptors
|
|
US6552023B2
(en)
|
2000-02-22 |
2003-04-22 |
Cv Therapeutics, Inc. |
Aralkyl substituted piperazine compounds
|
|
US6451798B2
(en)
|
2000-02-22 |
2002-09-17 |
Cv Therapeutics, Inc. |
Substituted alkyl piperazine derivatives
|
|
JP2001354657A
(ja)
|
2000-06-09 |
2001-12-25 |
Sds Biotech:Kk |
置換ピペラジン誘導体及び農園芸用殺菌剤
|
|
EP1170353B1
(en)
|
2000-07-06 |
2005-11-02 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and aligment promoter
|
|
WO2002064211A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
EP1372655B1
(en)
|
2001-03-02 |
2008-10-01 |
Merck Frosst Canada Ltd. |
Cathepsin cysteine protease inhibitors
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
FR2826011B1
(fr)
|
2001-06-14 |
2004-12-10 |
Oreal |
Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
|
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
EP1435946B8
(en)
|
2001-09-14 |
2013-12-18 |
Amgen Inc. |
Linked biaryl compounds
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
EP1693061A1
(en)
|
2002-10-04 |
2006-08-23 |
Ucb, S.A. |
Use of 4-aminoderivatives for the preparation of a medicament for treating neurological diseases
|
|
US7851486B2
(en)
|
2002-10-17 |
2010-12-14 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
|
|
AU2003290527A1
(en)
|
2002-10-17 |
2004-05-04 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction
|
|
WO2004058683A2
(en)
|
2002-12-20 |
2004-07-15 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
WO2004089410A1
(ja)
|
2003-04-03 |
2004-10-21 |
Kyowa Hakko Kogyo Co., Ltd. |
神経因性疼痛の予防及び／または治療剤
|
|
WO2004099164A1
(en)
|
2003-05-02 |
2004-11-18 |
Rigel Pharmaceuticals, Inc. |
Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
CN1856490A
(zh)
|
2003-07-28 |
2006-11-01 |
詹森药业有限公司 |
苯并咪唑、苯并噻唑和苯并噁唑衍生物及其作为lta4h调节剂的应用
|
|
US20050272051A1
(en)
|
2003-09-17 |
2005-12-08 |
Decode Genetics Ehf. |
Methods of preventing or treating recurrence of myocardial infarction
|
|
WO2005033079A1
(ja)
|
2003-09-30 |
2005-04-14 |
Eisai Co., Ltd. |
ヘテロ環化合物を含有する新規な抗真菌剤
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10356579A1
(de)
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
WO2005066238A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Medicinal compositions and method for the preparation thereof
|
|
DE602005015682D1
(de)
|
2004-02-04 |
2009-09-10 |
Neurosearch As |
Dimere azacyclische verbindungen und deren verwendung
|
|
WO2006033795A2
(en)
|
2004-09-17 |
2006-03-30 |
Wyeth |
Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
|
|
ES2570332T3
(es)
|
2005-03-16 |
2016-05-17 |
Meda Pharma Gmbh & Co Kg |
La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
|
|
US20060223792A1
(en)
|
2005-03-31 |
2006-10-05 |
Butler Christopher R |
Phenyl and pyridyl LTA4H modulators
|
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
US20070078263A1
(en)
|
2005-09-21 |
2007-04-05 |
Decode Chemistry, Inc. |
Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007079078A1
(en)
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
WO2007079003A2
(en)
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Amide inhibitors of leukotriene a4 hydrolase
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
US20100029619A1
(en)
|
2006-08-04 |
2010-02-04 |
Takeda Pharmaceutical Company Limted |
Fused heterocyclic compound
|
|
JP5167265B2
(ja)
|
2006-10-19 |
2013-03-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
微量アミン関連受容体に親和性を有するアミノメチル−２−イミダゾール
|
|
HRP20170621T1
(hr)
|
2006-12-14 |
2017-07-28 |
Janssen Pharmaceutica N.V. |
Postupak za pripremanje derivata piperazinil i diazepanil benzamida
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
CN101687844B
(zh)
|
2007-07-02 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr2受体拮抗剂的咪唑衍生物
|
|
AR068498A1
(es)
|
2007-09-27 |
2009-11-18 |
Merck & Co Inc |
Compuestos de oxadiazol para inhibicion de biosintesis de leucotrienos
|
|
WO2009074829A1
(en)
|
2007-12-12 |
2009-06-18 |
Astrazeneca Ab |
Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
|
|
US20110009429A1
(en)
|
2008-02-26 |
2011-01-13 |
Paul Oakley |
Heterocyclic compounds as inhibitors of cxcr2
|
|
FR2928070A1
(fr)
|
2008-02-27 |
2009-09-04 |
Sumitomo Chemical Co |
Composition agricole, utilisation d'un compose pour sa production et procede pour matriser ou prevenir les maladies des plantes.
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
SI2336125T1
(sl)
|
2008-04-11 |
2013-04-30 |
Janssen Pharmaceutica N.V. |
Tiazolopiridin-2-iloksi-fenil in tiazolopirazin-2-iloksi-fenil amini kot modulatorji levkotrien a4 hidrolaze
|
|
EP2110374A1
(en)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
|
WO2010011912A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Trpv4 antagonists
|
|
ES2399179T3
(es)
|
2008-08-07 |
2013-03-26 |
Pulmagen Therapeutics (Inflammation) Limited |
Tratamiento de enfermedad respiratoria
|
|
RU2589823C2
(ru)
|
2009-04-09 |
2016-07-10 |
Алкермес Фарма Айэленд Лимитед |
Композиция для доставки лекарственных средств
|
|
CN102030700B
(zh)
|
2009-09-30 |
2016-06-01 |
中国医学科学院药物研究所 |
苯甲酰胺基羧酸类化合物及其制法和药物用途
|
|
JP5781527B2
(ja)
|
2009-10-30 |
2015-09-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
４−置換−２−フェノキシ−フェニルアミンデルオピオイド受容体調節因子
|
|
PH12012501068A1
(en)
|
2009-12-07 |
2013-02-04 |
Targacept Inc |
3,6-diazabicyclo [3.1.1] heptanes as neuronal nicotinic acetylcholine receptor ligands
|
|
BR112013002112B1
(pt)
|
2010-07-29 |
2021-04-06 |
Rigel Pharmaceuticals, Inc. |
Composto, composição farmacêutica, e, uso de um composto, ou de um respectivo sal farmaceuticamente aceitável, ou de uma composição
|
|
WO2012067822A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
|
|
CA2835617C
(en)
|
2011-03-14 |
2020-07-21 |
Boehringer Ingelheim International Gmbh |
Benzodioxane inhibitors of leukotriene production
|
|
PH12013501882A1
(en)
|
2011-03-15 |
2013-10-14 |
Rib X Pharmaceuticals Inc |
Antimicrobial agents
|
|
KR101862291B1
(ko)
|
2011-04-12 |
2018-05-29 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
|
|
WO2012162407A1
(en)
|
2011-05-23 |
2012-11-29 |
Janssen Pharmaceutica Nv |
Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
|
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
|
CN103159742B
(zh)
|
2011-12-16 |
2015-08-12 |
北京韩美药品有限公司 |
5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9233089B2
(en)
|
2012-03-23 |
2016-01-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of pulmonary hypertension with leukotriene inhibitors
|
|
ES2864862T3
(es)
*
|
2013-03-12 |
2021-10-14 |
Celltaxis Llc |
Métodos de inhibición de la leucotrieno A4 hidrolasa
|
|
MX2015011677A
(es)
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|
|
RU2678196C2
(ru)
|
2013-03-14 |
2019-01-24 |
Селтакссис, Инк. |
Производные 2-фениламино-3-цианопиразоло[1,5-а]пиримидина, полезные в качестве ингибитора лейкотриен-a4-гидролазы
|
|
WO2014152536A2
(en)
|
2013-03-14 |
2014-09-25 |
Celtaxsys, Inc. |
Inhibitors of leukotriene a4 hydrolase
|
|
US9480676B2
(en)
*
|
2014-05-15 |
2016-11-01 |
Celgene Corporation |
Use of PDE4 inhibitors and combinations thereof for the treatment of cystic fibrosis
|
|
MA41253A
(fr)
*
|
2014-12-23 |
2017-10-31 |
Proteostasis Therapeutics Inc |
Composés, compositions et procédés pour augmenter l'activité du cftr
|
|
HUP1600271A2
(hu)
*
|
2016-04-25 |
2017-10-30 |
Druggability Tech Ip Holdco Ltd |
Ivacaftor és Lumacaftor sóinak és származékainak komplexei, eljárás azok elõállítására és azok gyógyszerészetileg elfogadható készítményei
|
|
EP3801559B1
(en)
*
|
2018-05-31 |
2025-01-01 |
Celltaxis, LLC |
Method of reducing pulmonary exacerbations in respiratory disease patients
|